Invention Grant
US08388963B2 Antitumor combinations containing a VEGF-inhibiting agent and 5FU or a derivative thereof
有权
含有VEGF抑制剂和5FU或其衍生物的抗肿瘤组合
- Patent Title: Antitumor combinations containing a VEGF-inhibiting agent and 5FU or a derivative thereof
- Patent Title (中): 含有VEGF抑制剂和5FU或其衍生物的抗肿瘤组合
-
Application No.: US12508834Application Date: 2009-07-24
-
Publication No.: US08388963B2Publication Date: 2013-03-05
- Inventor: Patricia Vrignaud , Marielle Chiron-Blondel , Marie-Christine Bissery , Eric Furfine , Jocelyn Holash , Jesse M. Cedarbaum
- Applicant: Patricia Vrignaud , Marielle Chiron-Blondel , Marie-Christine Bissery , Eric Furfine , Jocelyn Holash , Jesse M. Cedarbaum
- Applicant Address: FR Antony US NY Tarrytown
- Assignee: Aventis Pharma SA,Regeneron Pharmaceuticals Inc
- Current Assignee: Aventis Pharma SA,Regeneron Pharmaceuticals Inc
- Current Assignee Address: FR Antony US NY Tarrytown
- Agent Sandra Brockman-Lee
- Priority: FR0412870 20041203
- Main IPC: A61K38/18
- IPC: A61K38/18 ; C07K14/71 ; C12N15/62
Abstract:
This invention relates to antitumor combinations comprising a VEGF inhibitor combined with 5-fluorouracil or with a 5-fluoropyrimidine derivative that are therapeutically useful in the treatment of neoplastic diseases, and pharmaceutical compositions comprising such combinations.
Public/Granted literature
- US20090285841A1 ANTITUMOR COMBINATIONS CONTAINING A VEGF-INHIBITING AGENT AND 5FU OR A DERIVATIVE THEREOF Public/Granted day:2009-11-19
Information query
IPC分类:
